Skip to main content
main-content
Top

11-09-2017 | Dabrafenib | Article

Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial

Planchard D et al. Lancet Oncol 2017; 18(10):1307-1316. doi:10.1016/S1470-2045(17)30679-4

Please log in to get access to this content

Related topics